SCGB3A1

VALUE_ERROR (nil)
Identifiers
Aliases
External IDs	GeneCards: [1]
Orthologs
Species	Human	Mouse
Entrez	n/a	n/a
Ensembl	n/a	n/a
UniProt	n/a	n/a
RefSeq (mRNA)	n/a	n/a
RefSeq (protein)	n/a	n/a
Location (UCSC)	n/a	n/a
PubMed search	n/a	n/a
Wikidata
View/Edit Human

Secretoglobin family 3A member 1 is a protein that in humans is encoded by the SCGB3A1 gene.

Further reading

• Porter D, Lahti-Domenici J, Torres-Arzayus M, et al. (2003). "Expression of high in normal-1 (HIN-1) and uteroglobin related protein-1 (UGRP-1) in adult and developing tissues". Mech. Dev. 114 (1–2): 201–4. doi:10.1016/S0925-4773(02)00056-4. PMID 12175512.
• Reynolds SD, Reynolds PR, Pryhuber GS, et al. (2003). "Secretoglobins SCGB3A1 and SCGB3A2 define secretory cell subsets in mouse and human airways". Am. J. Respir. Crit. Care Med. 166 (11): 1498–509. doi:10.1164/rccm.200204-285OC. PMID 12406855.
• Niimi T, Copeland NG, Gilbert DJ, et al. (2003). "Cloning, expression, and chromosomal localization of the mouse gene (Scgb3a1, alias Ugrp2) that encodes a member of the novel uteroglobin-related protein gene family". Cytogenet. Genome Res. 97 (1–2): 120–7. doi:10.1159/000064067. PMID 12438750.
• Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
• Krop I, Maguire P, Lahti-Domenici J, et al. (2003). "Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors". Cancer Res. 63 (9): 2024–7. PMID 12727813.
• Bin LH, Nielson LD, Liu X, et al. (2003). "Identification of uteroglobin-related protein 1 and macrophage scavenger receptor with collagenous structure as a lung-specific ligand-receptor pair". J. Immunol. 171 (2): 924–30. doi:10.4049/jimmunol.171.2.924. PMID 12847263.
• Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment". Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.
• Fackler MJ, McVeigh M, Evron E, et al. (2004). "DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma". Int. J. Cancer. 107 (6): 970–5. doi:10.1002/ijc.11508. PMID 14601057.
• Tisserand P, Fouquet C, Barrois M, et al. (2004). "Lack of HIN-1 methylation defines specific breast tumor subtypes including medullary carcinoma of the breast and BRCA1-linked tumors". Cancer Biol. Ther. 2 (5): 559–63. doi:10.4161/cbt.2.5.511. PMID 14614327.
• Marchetti A, Barassi F, Martella C, et al. (2004). "Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome". Clin. Cancer Res. 10 (4): 1338–43. doi:10.1158/1078-0432.CCR-1174-03. PMID 14977834.
• Zhang Z, Henzel WJ (2005). "Signal peptide prediction based on analysis of experimentally verified cleavage sites". Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMC 2286551. PMID 15340161.
• Krop I, Player A, Tablante A, et al. (2005). "Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types". Mol. Cancer Res. 2 (9): 489–94. PMID 15383627.
• Shigematsu H, Suzuki M, Takahashi T, et al. (2005). "Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies". Int. J. Cancer. 113 (4): 600–4. doi:10.1002/ijc.20622. PMID 15472908.
• Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
• Krop I, Parker MT, Bloushtain-Qimron N, et al. (2005). "HIN-1, an inhibitor of cell growth, invasion, and AKT activation". Cancer Res. 65 (21): 9659–69. doi:10.1158/0008-5472.CAN-05-1663. PMID 16266985.
• Yang Q, Kiernan CM, Tian Y, et al. (2007). "Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome". Clin. Cancer Res. 13 (11): 3191–7. doi:10.1158/1078-0432.CCR-06-2846. PMID 17545522.
• Wu Q, Lothe RA, Ahlquist T, et al. (2007). "DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets". Mol. Cancer. 6: 45. doi:10.1186/1476-4598-6-45. PMC 1964763. PMID 17623056.